CNN2 and hepatocellular carcinoma: To investigate the potential of CNN2 for diagnosing, treating, and predicting the prognosis of HCC, we employed an indirect ELISA method using recombinant CNN2 protein-coated ELISA plates to detect anti-CNN2 antibodies in the serum from patients with primary liver cancer, hepatitis cirrhosis, and normal controls.